Policy Communications

2009 Annual Report

…working toward a world free of HIV/AIDS

NASTAD’s mission i s t o s t reng then s t a t e and t e r r i to r y -b a s e d l e a d e r s h i p , e x p e r t i s e , a n d a d v o c a c y a n d b r i n g t h e m to bea r in reduc ing the inc idence o f HIV in f e c t ion and on p rov id ing c a re and suppor t to a l l who l i ve w i th HIV/AIDS.

Technical Assistance Partnerships

NASTAD Officers/Executive Committee

2009 OfficersHeather Hauck, Maryland, ChairSigga Jagne, Kentucky, Vice Chair

Judy Norton, Arizona, Secretary-TreasurerAnn Robbins, Texas, Chair-Elect

Ex-Officio/NASTAD Past ChairTom Liberti, Florida

Executive DirectorJulie Scofield

2009 Executive Committee MembersMichelle Roland, California

Shannon Hader, District of ColumbiaRalph Wilmoth, Colorado

Peter Whiticar, HawaiiRandy Mayer, Iowa

Amna Osman, MichiganPeter Carr, MinnesotaLaurie Kops, Montana

Carmine Grasso, New JerseyHumberto Cruz, New York

Bill Tiedemann, OhioGreduvel Duran, Puerto Rico

Kathy Hafford, VirginiaJim Vergeront, Wisconsin

3

Message From The Chair Colleagues, Partners, Friends: It is my pleasure to present the 2009 Annual Report of the National Alliance of State and Territorial AIDS Directors (NASTAD). As the organization that represents the nation’s state health agency leaders with pro-grammatic responsibility for HIV/AIDS and viral hepatitis health care, prevention, education, and support-ive service programs throughout all 50 U.S. states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and U.S.-affiliated Pacific Islands, NASTAD is uniquely positioned to understand the critical role state health departments play in combating these epidemics.

Through its policy, communications, technical assistance and partnerships, NASTAD emphasizes the broad responsibility state health departments have for the provision of essential public health services including surveillance, epidemiology, and prevention of disease; primary health care services for the uninsured and indigent; and planning, coordination, administration, and fiscal management of public health services. As the current NASTAD Chair, I saw firsthand how NASTAD effectively utilizes these four pillars of work to achieve its two overarching goals: 1.) to assert the role of state public health HIV/AIDS and viral hepatitis programs; and 2.) to reduce racial/ethnic health disparities in the HIV/AIDS and viral hepatitis epidemics.  This past year has been one of the most difficult periods that state HIV/AIDS and viral hepatitis programs have experienced. The state budget crises we have faced have led to unprecedented challenges in maintain-ing an effective and vibrant workforce, maintaining program efforts, and in advancing our efforts to achieve policy and program successes. In the face of this, NASTAD was ever vigilant in documenting and voicing the impact of this crisis through its Survey of State Health Department Budget Cuts. NASTAD focused more TA on meeting the growing needs of struggling state programs. By the end of 2009, NASTAD was well poised to help states address these significant challenges while continuing to provide high quality HIV/AIDS and viral hepatitis programs.

As we move into the next year facing the ongoing fiscal climate and the new challenges of advancing impor-tant policy changes through health care reform, I have no doubt that the collective efforts of my state AIDS director colleagues and the expert NASTAD staff working to assert our role, support effective programs and reduce health disparities in the HIV/AIDS and viral hepatitis epidemics will result in progress in the years to come.

Sincerely, Heather Hauck, NASTAD ChairDirector of Infectious Diseases and Environmental Health AdministrationMaryland Department of Health and Mental Hygiene

4

NASTAD Develops Sound Public Policy and Advocacy Strategies

NASTAD’s government relations and public policy focuses on educating Congress, the Administration, national and community-based organizations, and pri-vate industry about the role of states and territories in addressing HIV/AIDS and viral hepatitis. NASTAD policy and advocacy work focuses on federal resources and legislation to support state health department programs. Significant progress was made on a num-ber of critical policy issues in 2009, among them:

Ryan White Program ReauthorizationNASTAD worked to ensure that the Ryan White Program was reauthorized in 2009 for another four years. The final legislation closely followed the recommendations included in the Community Consensus document developed by the Ryan White Work Group, co-chaired by NASTAD, securing over 300 endorsements for the Community Consensus. NASTAD worked tirelessly to spur action to reau-thorize the Ryan White Program, participating in individual and group briefings of Congressional staff and working closely with House and Senate staff to provide critical feedback on the bill. These efforts were rewarded when the bill was signed into law by President Obama on October 30, 2009.

NASTAD Executive Director Julie Scofield was one of three advocates present for the signing.

Federal Funding of HIV and Viral Hepatitis A significant focus for NASTAD is to ensure that state and local health departments receive appropri-ate federal resources to address HIV and viral hepa-titis. The President’s proposed FY2010 budget included increases for HIV care and prevention and viral hepatitis programs and much of what the President proposed was included in the FY2010 Consolidated Appropriations bill. Given the ongo-ing realities of state budget deficits and a tight fed-eral budget, NASTAD will continue to focus sig-nificantly on advocating for the necessary resources for HIV/AIDS, viral hepatitis and STD programs.

Prevention Blueprint/Policy AgendaNASTAD continued to advocate for increased resources and effective policy to strengthen domes-tic HIV prevention programs. NASTAD’s A New

Blueprint for the Future: Ending the HIV/AIDS Epidemic Through the Power of Prevention, and its companion, Prevention Policy Agenda, were front and center throughout NASTAD’s prevention advocacy in 2009. Key messages to invest in pro-grams that are working on the local level and move important policies forward came to fruition in 2009 with the lifting of the federal ban on funding for syringe exchange programs and the elimination of the majority of targeted funding for abstinence-only-until-marriage programs.

National HIV/AIDS Strategy NASTAD provided detailed comments to the White House Office of National AIDS Policy (ONAP) in 2009 to inform the development of the National HIV/AIDS Strategy (NHAS). NASTAD also participated in population–specific meetings at the White House and community consultations that provided recommendations on specific topic areas. NASTAD urged ONAP to ensure that the role of state health departments as primary imple-menters is strongly represented in the final strategy.

Health Reform LegislationNASTAD was an active advocate for expanded access to care for people living with HIV/AIDS and viral hepatitis in health reform by co-chairing the HIV Health Care Access Working Group. NASTAD also joined colleagues in the Association of State and Territorial Health Officials’ Affiliate Council to advocate for dedicated funding for pre-vention and public health.

Viral Hepatitis AdvocacyNASTAD convenes the Hepatitis C Appropriations Partnership, which includes community, providers, public health and industry and seeks to increase federal resources for viral hepatitis. NASTAD advocacy contributed to the first-ever combined hepatitis B and C authorization legislation, the Viral Hepatitis and Liver Cancer Prevention and Control Act of 2009 (H.R.3974), intended to authorize the provision of comprehensive preven-tion, education, research and medical management referral programs for people at risk for and chroni-cally infected with hepatitis B and C.

Policy

5

NASTAD Communicates Information about Health Department HIV/AIDS and Viral Hepatitis Programs

Effective communication is a cornerstone of NASTAD’s strategy to support state HIV/AIDS and viral hepatitis programs. NASTAD uses mul-tiple communication strategies to accomplish this goal. NASTAD shares the perspectives and issues facing state HIV/AIDS and viral hepatitis programs with federal agencies, industry partners, foundations and other important stakeholders. Effectively alerting state program staff to legislative and administrative policies and developments also ensures our members have the most up-to-the-minute information necessary to manage their pro-grams and deal with the funding crises they face.

Major accomplishments in 2009 included:

The National Prevention InventoryIn collaboration with the Kaiser Family Foundation, NASTAD issued a comprehensive inven-tory of the preven-tion services being funded by health departments through funding from both

CDC and state-appropriated dollars. NASTAD’s analysis in The National Prevention Inventory describes the breadth of prevention services man-aged by state and local health departments, as well as their outstanding needs, in order to better chart the future of the response to the epidemic in the U.S.

National ADAP Monitoring ReportNASTAD and the Kaiser Family Foundation released the 13th National ADAP Monitoring Project Report on April 7, 2009 via live webcast. The report, based on a compre-hensive survey of

ADAPs in the 50 states, the District of Columbia, territories, and associated jurisdictions, documents new developments and challenges facing ADAPs, assesses key trends over time, and provides the lat-est data on the status of these programs.

Viral Hepatitis Webinar SeriesIn 2009, NASTAD increased communication about viral hepatitis to health departments and community partners through webinars, including the webinar focused on strategies for developing effective media messaging and working with the media. Another webinar featured a Prevention Branch Update from the CDC Division of Viral Hepatitis.

State Budget Cuts The 2009 NASTAD State Budget Cuts Report pro-vided summary results of NASTAD’s budget cuts surveys to HIV and viral hepatitis programs. These surveys suggest that cuts are occurring on a rolling basis as state deficit projections are revised through-out the year and found that in FY2009, more than $170 million was cut from program budgets, with fifty percent of all jurisdictions receiving cuts. NASTAD will use this data in on-going advocacy for additional federal appropriations as well as to contextualize the impact of state fiscal crises on HIV and viral hepatitis services. 

New Media StrategiesNew technologies and strategies for reach-ing constituents and stakeholders has been an untapped public health resource, but NASTAD took steps in 2009 to offer its membership new ways to capitalize on new media to reach

their communities and their grantees. At the 2009 NASTAD Annual Meeting, NASTAD demon-strated the potential of social networking sites like Facebook and Twitter, as well as the possibilities of podcasts and other new media, and continued to explore avenues to reach its membership with these mechanisms through 2009. Blogging, webinars and podcasts are now among the communication strate-gies NASTAD’s uses to reach AIDS directors and their staff and ensure they receive ‘real time’ updates on HIV, STD and viral hepatitis information.

Communications

6

Technical Assistance NASTAD builds the capacity of HIV/AIDS and

viral hepatitis programs in U.S. state and territorial health departments and international in-country HIV/AIDS programs, as well as the capacity of indi-viduals within these agencies, through the provision of peer-based technical assistance (TA) responsive to needs identified by health departments.

In 2009…NASTAD leveraged the expertise of staff and its network of peer TA providers to strengthen the health department response to addressing the dis-proportionate epidemics among racial and ethnic minority communities, in particular black gay men, black women and Latino gay men, as well as persons who use injection drugs. State-based strategies to increase testing in these communities, to establish routine testing in clinical settings and address the challenges in AIDS Drug Assistance Programs (ADAPs) were among NASTAD’s major TA emphases in 2009.

NASTAD provided TA focused on:

• Expanding health departments’ ability

to provide testing in clinical settings and

expanded testing in African American and

Latino communities

• Sharing strategies for reaching gay men

using the Internet and Internet partner

services

In 2009, NASTAD ramped up efforts to shar-ing strategies to address the epidemic among black gay men, including for example, work-ing with the Arkansas Department of Health (ADH) to assess risk behaviors and social networks among black gay men/black MSM attending the Little Rock Pride event.

• Building ADAP program management

skills during the annual ADAP conference

• Strengthening the ability of the Arizona

Department of Health Services and its

partners to implement HIV and viral

hepatitis programs targeting Latino com-

munities using the NASTAD Call to Action,

ADELANTE! Strengthening the Response to HIV/AIDS and Viral Hepatitis in Latino Communities

• Working with the Harm Reduction

Coalition to gather best practices for

expanding syringe access as a strategy to

reduce HIV transmission among those who

inject drugs

• Convening a Leadership Institute, with

funding from the Johnson & Johnson

Foundation to help new and emerging

leaders develop critical skills necessary

to lead state HIV/AIDS and viral hepatitis

programs.

NASTAD Delivers Expert Technical Assistance

NASTAD conducted its third Regional Forum, "Black Women and HIV/AIDS: Confronting the Crisis and Planning for Action" with the Southern AIDS Coalition to build knowledge and skills on priorities, resources, and facilitators and barriers to effective programming targeting black women.

7

South Africa

Botswana

Zambia

Ethiopia

Haiti

NASTAD COUNTRIES, 2010

NASTAD’s Global Program is funded by the U.S. Centers for Disease Control and Prevention Global AIDS Program (CDC/GAP), through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Modeled after NASTAD’s domestic peer-to-peer TA program, the Global Program is designed to facilitate peer exchange among U.S. state AIDS directors and AIDS program staff with national, state, and regional AIDS committees and AIDS programs in PEPFAR countries.

HaitiIn Haiti, NASTAD provides training on the con-cepts, theory, and practice of HIV case notification, and the use of surveillance data for program and policy management. Using community-level feed-back and an assessment of Haiti’s HIV surveillance and case notification systems, NASTAD revised Haiti’s National HIV Case Surveillance Operations Manual.

EthiopiaNASTAD’s primary goal in Ethiopia is to strengthen the capacity of regional HIV preven-tion coordinating offices through assistance with a national social mobilization intervention known as Community Conversations. In 2009, NASTAD expanded its community-level activities to include prevention interventions and promoting increased local awareness to most at-risk populations.

ZambiaNASTAD worked in partnership with CDC/Zambia and Zambia’s National AIDS Council (NAC) to provide HIV program monitoring and evaluation (M&E) TA and capacity building. NASTAD provided targeted TA to four provinces to build the capacity of the community and district workers responsible for HIV/AIDS to conduct M&E and built national-level capacity at through a Center of Excellence at the University of Zambia.

BotswanaIn Botswana, NASTAD provided technical assis-tance to all district multi-sectoral AIDS committees for the development of annual evidence-based HIV plans. In 2009, NASTAD supported implementa-tion of planned activities in five districts by provid-ing organizational and programmatic TA to twelve small HIV prevention implementing partners

South AfricaNASTAD worked with CDC/South Africa to sup-port twinning relationships between three provinces and three U.S. state programs: the Massachusetts Department of Health (MDPH) and the Eastern Cape Health Department (ECHD); the Illinois Department of Health (IDPH) and the Northern Cape Health Department (NCHD); and the Indiana Health Department (ISHD) and the Free State Province Health Department (FSPHD).

Global Technical Assistance

NASTAD Countries 2009

Technical Assistance

8

NASTAD Establishes Partnerships To Achieve Its Goals

Recognizing that effective responses to the HIV/AIDS and viral hepatitis epidemics require collec-tive action, NASTAD establishes partnerships with important entities to achieve its goals. In 2009, NASTAD continued to expand and build upon these established partnerships:

The Administration and Federal PartnersNASTAD has long recognized that the ability of states to successfully implement programs is dependent on relationships with the federal gov-ernment. To foster these connections, NASTAD develops strong working relationships with the Administration and its health-related agen-cies. Early in 2009, NASTAD weighed in with the Obama Transition Team, asking that they consider individuals with specific attributes for key HIV-related leadership positions in the new Administration.

Similarly, NASTAD led efforts of the Hepatitis C Appropriations Partnership (HCAP) to develop viral hepatitis recommendations for the Obama Administration’s first 100 days.

NASTAD shared its Prevention Blueprint and Policy Agenda with Secretary Sebelius and regu-larly met with key representatives in the Office of National AIDS Policy (ONAP) and the Office of Management and Budget (OMB) throughout 2009 to ensure that states were an essential partner in the development of the National HIV/AIDS Strategy, as well as health reform.

NASTAD’s partnerships with the federal agencies that primarily fund state HIV/AIDS and viral hepatitis programs remained strong throughout 2009. Work with the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) on programmatic and policy levels ensured open flow of communication and devel-opment of shared understandings of health depart-ment resource and programmatic needs. The Community NASTAD continued its strong partnership with community through participation in the Federal AIDS Policy Partnership (FAPP), AIDS in America, and the National Viral Hepatitis Roundtable. Through the FAPP Ryan White Working Group, NASTAD advanced the HIV/AIDS Community Consensus on the Future of the Ryan White HIV/AIDS Treatment Modernization Act. Passing new Ryan White Program authorizing legislation with-out this strong relationship with community part-ners would have been very difficult.

NASTAD works with other community advocacy coalitions to achieve mutual goals as well. For example, NASTAD continued to participate in the National

Black Gay Men’s Advocacy Coalition to ensure that the needs of black gay men remained high on the national HIV/AIDS agenda. NASTAD also partnered with the Harm Reduction Coalition to develop recommenda-tions for expanding syringe access.

Public Health NASTAD works in partnership with other state-based governmental health organizations through the Association of State and Territorial Health Official’s Affiliate Council. NASTAD also partici-pates in the American Public Health Association’s CDC Coalition and Friends of HRSA as well as the Campaign for Public Health.

FoundationsNASTAD continues to build relationships with major foundations dedicated to innovative strate-gies to address the domestic HIV/AIDS and viral hepatitis epidemics. NASTAD expanded its part-nership with the Kaiser Family Foundation in 2009 to include collaboration on the “SOY…” (I AM…) campaign. “SOY…” is a groundbreaking pub-lic information campaign that confronts stigma, debunks myths and empowers Latino communities to take action in the fight against HIV/AIDS. Through its partnership with the Johnson & Johnson Foundation, NASTAD published a series of Leadership Development and Workforce Issue Briefs and further developed leadership tools and training focused on addressing the leadership and workforce needs of state HIV/AIDS and viral hepatitis programs.

IndustryNASTAD’s partnership with industry remained strong in 2009, bolstered by a shared need to ensure that state ADAP programs remained cost effective and efficient and that prevention technologies were broadly accessible and rapidly deployed in each and every jurisdiction in the most appropriate manner.

One example of our critical partnerships with industry is the partnership with OraSure Technologies focused on viral hepatitis. In August 2009, NASTAD co-hosted a meeting with OraSure to bring both viral hepatitis industry and advocacy partners together for the inaugural formation of an industry alliance focused on increasing advocacy for a national response to viral hepatitis.

Partnerships

9

In the next decade, states and territories will play an integral role in the implementation of the National HIV/AIDS Strategy (NHAS). States have critical roles in meeting the three goals of the NHAS strategy – reducing HIV incidence, increas-ing access to care and optimizing health outcomes, and reducing HIV-related health disparities. States receive about half of the federal Ryan White and CDC prevention funding and more importantly, continue to contribute significant state resources to their programs.  State health departments are targeting their resources and designing programs to address highly impacted populations (e.g., gay men of all races, blacks, Latinos). 

Yet health departments remain challenged in adminis-tering HIV and viral hepatitis prevention and care pro-grams with insufficient federal and/or state resources. These limitations will significantly impact the delivery and availability of services to people infected with and at risk for infection. Federal and state funding has not kept pace with the increasing number of clients health department programs are seeing.  The economic down-turn has resulted in record enrollment increases.  Cuts in surveillance funding are also eroding already fragile core HIV/AIDS surveillance systems - flat-funded for a decade while the use of the data is critical in order to monitor the HIV/AIDS epidemic and to provide data for targeting the delivery of HIV prevention, care, and treatment services. States receive no federal funding to support viral hepatitis core public health services such as counseling, testing and referral, adult vaccination pro-grams, chronic HBV and HCV surveillance or mono-infection care and treatment.

Furthermore, state HIV/AIDS programs are responsible for ensuring coordination of all state and federal funding for HIV care and preven-tion programs, regardless of where the funding is directed.  Yet federal funding to states is provided in silos with numerous applications and different administrative, reporting and evaluation require-ments throughout the year.  In 2009, NASTAD developed a graphic representation of 71 separate federal reporting requirements for just CDC’s HIV prevention, surveillance, expanded testing initiative, viral hepatitis, and sexually transmitted diseases cooperative agreements and HRSA’s Ryan White Part B care and ADAP grants.  This does not include the myriad other programs that states may administer including Ryan White Part D, boutique surveillance projects, HOPWA or SAMHSA. It is important that NASTAD tell this story to build

greater understanding of the importance of the role of state-based public health.

NASTAD is also acutely aware of the looming public health workforce crisis and crumbling public health infrastructure that threaten our ability to protect the health and wellness of the individu-als and communities we serve. This awareness is heightened by the understanding that if we do not take action to reverse these trends, the HIV/AIDS and viral hepatitis epidemics will further expand and the existing disparities among racial and ethnic minority communities, gay men of all races and persons who inject drugs will only get worse.

To ensure NASTAD remains well poised to con-tinue its strong advocacy for state HIV/AIDS and viral hepatitis programs, NASTAD engaged its membership in a strategic planning process in 2009 that will serve as the cornerstone for our work in the coming years. Through policy leadership, effec-tive communication, comprehensive technical assis-tance and strong partnerships, NASTAD remains committed to strengthening the role and promot-ing the success of state and territorial public health programs in reducing HIV/AIDS and viral hepati-tis incidence and provide care and treatment.

The collective “we” know what needs to be done. As a nation, we must commit to ending the HIV/AIDS and viral hepatitis epidemics through the power of prevention. NASTAD’s “Blueprint for the Future” and companion policy action plan show the way. These steps must be accompanied by a commitment to care and treatment for all individuals infected and affected by HIV/AIDS and viral hepatitis and the national will to provide the funding necessary to restore the devastating cuts of the last eight years and scale-up funding for the HIV/AIDS, viral hepatitis, STD, and TB programs that we know can, and will, make a difference in our communities.

Julie M. Scofield Executive DirectorNASTAD

Closing Statement from NASTAD’s Executive DirectorWhere We Are Going

All data listed above from audited financial statements.

2009 2008Total Total

SUPPORT AND REVENUEGrants and Contributions 7,030,659$ 6,037,295$ Membership Dues 540,000 538,456 Registration Fees 29,725 33,000 Interest 27,660 58,774 Other 11,725 13,952 Net Assets Released from Restrictions - Total Support and Revenue 7,639,769 6,681,477

EXPENSESProgram Services 6,732,539 5,572,203 Supporting Services: General and Administration 634,955 814,330 Overhead 397,879 338,779 Advocacy 40,735 46,198 Fundraising 40,116 25,877 Total Supporting Services 1,113,685 1,225,184 Total Expenses 7,846,224 6,797,387

CHANGE IN NET ASSETS (206,455) (115,910)

Net Assets - Beginning of Year 1,461,770 1,577,680

NET ASSETS - END OF YEAR 1,255,315$ 1,461,770$

NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSCOMPARATIVE STATEMENT OF ACTIVITIES

YEAR ENDED SEPTEMBER 30

0

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

1 2 3 4 5

Grants and Contributions

Membership Dues

Registration Fees

Interest

Other

2009 2008

REVENUE

0

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

Program ServicesGeneral and

AdministrationOverhead

Advocacy

Fundraising

EXPENSES

DonorsNASTAD graciously thanks all of its supporters for their financial contributions in 2009.

FederalU.S. Health Resources and Services Administration (HRSA)

U.S. Centers for Disease Control and Prevention (CDC) National Institutes of Health via Academy for Educational Development (AED)

FoundationsHenry J. Kaiser Family Foundation

Johnson & Johnson Foundation

CorporateAbbott Laboratories

Boehringer Ingleheim Bristol-Myers Squibb

CVS Caremark Specialty PharmacyGilead Sciences

GlaxoSmithKlineInverness Medical

Monogram BiosciencesPfizer

Orasure TechnologiesRamsell Public Health RX

RocheTibotec Therapeutics

Trinity BiotechVertex

All data listed above from audited financial statements.

2009 2008Total Total

SUPPORT AND REVENUEGrants and Contributions 7,030,659$ 6,037,295$ Membership Dues 540,000 538,456 Registration Fees 29,725 33,000 Interest 27,660 58,774 Other 11,725 13,952 Net Assets Released from Restrictions - Total Support and Revenue 7,639,769 6,681,477

EXPENSESProgram Services 6,732,539 5,572,203 Supporting Services: General and Administration 634,955 814,330 Overhead 397,879 338,779 Advocacy 40,735 46,198 Fundraising 40,116 25,877 Total Supporting Services 1,113,685 1,225,184 Total Expenses 7,846,224 6,797,387

CHANGE IN NET ASSETS (206,455) (115,910)

Net Assets - Beginning of Year 1,461,770 1,577,680

NET ASSETS - END OF YEAR 1,255,315$ 1,461,770$

NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSCOMPARATIVE STATEMENT OF ACTIVITIES

YEAR ENDED SEPTEMBER 30

0

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

1 2 3 4 5

Grants and Contributions

Membership Dues

Registration Fees

Interest

Other

2009 2008

REVENUE

0

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

Program ServicesGeneral and

AdministrationOverhead

Advocacy

Fundraising

EXPENSES

DonorsNASTAD graciously thanks all of its supporters for their financial contributions in 2009.

FederalU.S. Health Resources and Services Administration (HRSA)

U.S. Centers for Disease Control and Prevention (CDC) National Institutes of Health via Academy for Educational Development (AED)

FoundationsHenry J. Kaiser Family Foundation

Johnson & Johnson Foundation

CorporateAbbott Laboratories

Boehringer Ingleheim Bristol-Myers Squibb

CVS Caremark Specialty PharmacyGilead Sciences

GlaxoSmithKlineInverness Medical

Monogram BiosciencesPfizer

Orasure TechnologiesRamsell Public Health RX

RocheTibotec Therapeutics

Trinity BiotechVertex

444 North Capitol Street, NW • Suite 339Washington, DC 20001-1512

www.NASTAD.org